Head and Neck Cancer Clinical Trials

A listing of Head and Neck Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Mirati Research Site
Birmingham Alabama 35294

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

View More ▼

Birmingham Alabama 35294

A Phase 1 clinical study for patients using SGN-2FF

Birmingham Alabama 35294

A Phase 1/1b clinical study for patients with Advanced Cancer

Arizona

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Arkansas

Little Rock Arkansas 72205

A clinical research study of nab-paclitaxel, Cisplatin, Carboplatin and Cetuximab for the treatment of Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma or Cancer of the Head and Neck

California

Mirati Research Site
La Jolla California 92037

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

Mirati Research Site
Orange California 92868

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

The Stanford Center for Clinical and Translational Education and Research Recruiting
Palo Alto California 94304

An Open-Label Study of Varlilumab and Nivolumab in Head and Neck, Ovarian, Renal, Colorectal and GBM Cancers

Mirati Research Site
San Diego California 92093

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Mirati Research Site
San Francisco California 94115

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

View More ▼

Duarte California 91010

A clinical trial to evaluate treatments for patients with Head and Neck Cancer

Duarte California 91010

A clinical trial to evaluate treatments using APX005M for patients with Cancer, Carcinoma, Neoplasms or Neoplasm Metastasis

Duarte California 91010-3000

A Phase 1 clinical study for patients using SGN-2FF

Duarte California 91010

A Phase 2 clinical study for patients with Head and Neck Cancer

La Jolla California 92093

A clinical trial seeking patients for a research study of Pembrolizumab, Cetuximab

La Jolla California 92093-0698

A Phase 1 clinical study for patients using pembrolizumab (MK-3475), Cisplatin and Radiation

La Jolla California 92093

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

La Jolla California 92093

Patients are needed to participate in a clinical research study of OncAlert to evaluate Oral Cavity Squamous Cell Carcinoma, Oropharynx Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oropharynx or Squamous Cell Carcinoma of the Head and Neck

Los Agneles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90033

A clinical trial to evaluate treatments using INT230-6, anti-PD-1 and anti-PD-1 antibody for patients

Los Angeles California 90095

A clinical trial to evaluate treatments using MGA271 for patients

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90095

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90024

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90095-6984

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90095

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90025

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90048

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Los Angeles California 90033

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Newport Beach California 92663

A clinical trial to evaluate treatments using INT230-6, anti-PD-1 and anti-PD-1 antibody for patients

Sacramento California 95817

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

San Diego California 92093

A Phase 1/1b clinical study for patients with Advanced Cancer

San Francisco California 94143

A Phase 1/1b clinical study for patients with Advanced Cancer

San Francisco California 94115

A Phase 2 clinical study for patients with Locally Advanced Basal Cell Carcinoma, Skin Cancer or Cutaneous Malignancy

San Francisco California 94115

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

San Francisco California 94143

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Santa Monica California 90403

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Santa Monica California 90404

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Santa Monica California 90404

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Santa Monica California 90404

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Santa Monica California 90403

Patients are needed to participate in a clinical research study of FPA008 and Nivolumab, Selected Advanced Cancers

Stanford California 94305

A clinical trial to evaluate treatments for patients with Head and Neck Cancer

Whittier California 90602

A Phase 1/1b clinical study for patients with Advanced Cancer

Colorado

University of Colorado Cancer Center
Aurora Colorado 80045

An Open-Label Study of Varlilumab and Nivolumab in Head and Neck, Ovarian, Renal, Colorectal and GBM Cancers

View More ▼

Aurora Colorado 80045-0510

A Phase 1 clinical study for patients using SGN-2FF

Denver Colorado

A clinical research study of MEDI4736 and INCB024360 for the treatment of Selected Advanced Solid Tumors

Connecticut

Smilow Cancer Hospital at Yale University Cancer Center Recruiting
New Haven Connecticut 06519

An Open-Label Study of Varlilumab and Nivolumab in Head and Neck, Ovarian, Renal, Colorectal and GBM Cancers

View More ▼

Farmington Connecticut 06030

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors